drugset / Trial / NCT04741087
Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase 2 Study Investigating the Efficacy of AMT-101 in Subjects with Chronic Antibiotic-resistant Pouchitis
Timeline
- Start
- 2021-02-05
- Primary completion
- 2022-03-11
- Completion
- 2022-04-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | VIMEKOFUSP | Protein / enzyme biologic | — | Oral |